KLK3 and Familial prostate cancer: Lacking results from a randomized Canadian trial of early versus delayed ADT in men with PSA failure following radiation (NCT00439751), decisions are typically made today in the context of comorbidity and adverse prostate cancer prognostic factors such as PSA doubling time and time to PSA failure.